Intermittent supplementation with fisetin improves arterial function in old mice by decreasing cellular senescence is a research paper published in Aging Cell (2023). On theSindex it has a DataRank of 0. It has been cited 90 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
National Institutes of Health
Grant: F31 HL165885
National Institutes of Health
Grant: F32 HL151022
National Institutes of Health
Grant: K01 DK115524
National Institutes of Health
Grant: K99 HL159241
National Institutes of Health
Grant: R01 AG055822
National Institutes of Health
Grant: R01 AG055822‐03S1
National Institutes of Health
Grant: R01AG055822‐04S1
NIH HHS
Grant: R01 AG055822-03S1
NIH HHS
Grant: R01AG055822-04S1
National Institutes of Health
Grant: 5K01DK115524-02
Sodium Nitrite Supplementation for Improving Physiological Function in Patients with Chronic Kidney Disease
National Institutes of Health
Grant: 5F31HL165885-03
Targeting cellular senescence with oral fisetin supplementation to improve vascular aging
National Institutes of Health
Grant: 5K99HL159241-02
Translational studies of cellular senescence as a regulator of doxorubicin-mediated arterial dysfunction
National Institutes of Health
Grant: 5F32HL151022-02
Mitochondrial oxidative stress: a target for treatment of doxorubicin-associated vascular endothelial dysfunction
National Institutes of Health
Grant: 3R01AG055822-04S1
Role of cellular senescence in cardiovascular aging
FWCI
21.24
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals